NCT06549361

A Retrospective Study on Extranodal DLBCL

The Retrospective Clinical Study of Extranodal Diffuse Large B-Cell Lymphoma

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 5,023 (actual)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to prospectively collect clinical information of patients with extranodal DLBCL, assess the effectiveness of treatment for extranodal DLBCL in the real world, and explore the optimal treatment strategies in real-world populations.

Detailed description

DLBCL is a highly common aggressive non-Hodgkin's lymphoma. For specific extranodal sites of DLBCL, traditional chemotherapy protocols often cannot provide satisfactory results for patients. The aim of this study is to prospectively collect clinical information of patients with extranodal DLBCL, including the distribution of involved sites (such as central nervous system, testes, skin, breast, gastrointestinal tract, etc.), prognosis of diffuse large B-cell lymphoma with involvement of different extranodal sites, genetic mutation characteristics, correlation with molecular subtypes, impact of different treatment regimens on efficacy, assess the effectiveness of treatment for extranodal DLBCL in the real world, and explore the optimal treatment strategies in real-world populations.

Conditions

• Lymphoma
• Extranodal Lymphoma
• Diffuse Large B Cell Lymphoma

Interventions

Type	Name	Description
OTHER	No interventions need to be specified for this study	No interventions need to be specified for this study

Timeline

• Start date: 2022-05-01
• Primary completion: 2023-07-01
• Completion: 2023-09-01
• First posted: 2024-08-12
• Last updated: 2024-08-12

Locations

1 site across 1 country: China